These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3856563)

  • 1. Mezlocillin, ceftizoxime, and amikacin alone and in combination against six Enterobacteriaceae in a neutropenic site in rabbits.
    Gerding DN; Peterson LR; Moody JA; Fasching CE
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():207-19. PubMed ID: 3856563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model.
    Peterson LR; Gerding DN; Moody JA; Fasching CE
    Antimicrob Agents Chemother; 1984 May; 25(5):545-52. PubMed ID: 6329087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model.
    Bamberger DM; Peterson LR; Gerding DN; Moody JA; Fasching CE
    J Antimicrob Chemother; 1986 Jul; 18(1):51-63. PubMed ID: 3093445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftazidime and amikacin alone and in combination against Pseudomonas aeruginosa and Enterobacteriaceae.
    Moody JA; Fasching CE; Peterson LR; Gerding DN
    Diagn Microbiol Infect Dis; 1987 Jan; 6(1):59-67. PubMed ID: 3100127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
    Moody JA; Gerding DN; Peterson LR
    Am J Med; 1987 Apr; 82(4A):44-54. PubMed ID: 3107380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of ureidopenicillins alone and in combination with amikacin and three cephalosporin antibiotics.
    Moody JA; Peterson LR; Gerding DN
    Antimicrob Agents Chemother; 1984 Aug; 26(2):256-9. PubMed ID: 6435516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the serum bactericidal activity of cefoperazone alone and in combination with amikacin or mezlocillin against gram-negative bacilli and Staphylococcus aureus.
    Lagast H; Klastersky J; Standiford H; Viollier A
    Infection; 1984; 12(3):190-3. PubMed ID: 6432702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
    Meyer RD; Pasiecznik K
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):287-93. PubMed ID: 6321092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of ciprofloxacin- and ceftizoxime-induced resistant gram-negative bacilli.
    Fasching CE; Gerding DN; Peterson LR
    Am J Med; 1987 Apr; 82(4A):80-6. PubMed ID: 3472465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum bactericidal activity of mezlocillin, ceftazidime, mezlocillin/ceftazidime and mezlocillin/amikacin against Klebsiella pneumoniae and Pseudomonas aeruginosa.
    Van Laethem Y; Klastersky J
    Eur J Clin Microbiol; 1986 Feb; 5(1):110-4. PubMed ID: 3084239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
    Schmalreck AF; Wildfeuer A
    Arzneimittelforschung; 1990 Oct; 40(10):1145-55. PubMed ID: 2291754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced in vitro bactericidal activity of amikacin or gentamicin combined with three new extended-spectrum cephalosporins against cephalothin-resistant members of the family Enterobacteriaceae.
    Bayer AS; Eisenstadt R; Morrison JO
    Antimicrob Agents Chemother; 1984 Jun; 25(6):725-8. PubMed ID: 6331297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antibacterial activity of ceftizoxime against gram-negative strains.
    Debbia E; Soro O
    Chemioterapia; 1985 Apr; 4(2):166-9. PubMed ID: 3891115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro activity of ciprofloxacin plus azlocillin against 12 streptococcal isolates in a neutropenic site model.
    Peterson LR; Moody JA; Fasching CE; Gerding DN
    Diagn Microbiol Infect Dis; 1987 Jun; 7(2):127-36. PubMed ID: 3115671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of pefloxacin.
    Husson MO; Izard D; Bouillet L; Leclerc H
    Drugs Exp Clin Res; 1986; 12(4):313-7. PubMed ID: 3522154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of antibiotic synergy in vitro and in vivo: use of an animal model of neutropenic gram-negative sepsis.
    Chadwick EG; Shulman ST; Yogev R
    J Infect Dis; 1986 Oct; 154(4):670-5. PubMed ID: 3528320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of cefotaxime and amikacin against 14,272 gram-negative bacteria from clinical samples in the period 1980 to 1985.
    Dámaso D; Sánchez-Moreno MP; Martínez-Martínez L; Mesa E; Portero F; Mendaza P; Daza RM
    Drugs; 1988; 35 Suppl 2():1-5. PubMed ID: 3396470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro microbiological properties of mezlocillin compared with four cephalosporins.
    Esposito S; Galante D; Barba D
    Chemioterapia; 1986 Aug; 5(4):273-7. PubMed ID: 3490314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mezlocillin: a new acyl ureidopenicillin. Antimicrobial activity and combination effects with four aminoglycoside antibiotics.
    Schassan HH; Koperski K; Scherf H
    Chemotherapy; 1978; 24(3):134-42. PubMed ID: 95925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo studies of three antibiotic combinations against gram-negative bacteria and Staphylococcus aureus.
    Zinner SH; Klastersky J; Gaya H; Bernard C; Ryff JC
    Antimicrob Agents Chemother; 1981 Oct; 20(4):463-9. PubMed ID: 6282192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.